Natural Biocon (India) Ltd Share Price Today - Natural Biocon (India) Ltd Stock Price Live NSE/BSE

Natural Biocon (India) Ltd

NSE: BSE: 543207

₹4.20

(-5.83%)

Tue, 03 Mar 2026, 00:22 pm

MTF 5xInvest in Natural Biocon (India) Ltd with 5x Leverage Buy with MTF

Market Cap108.29M

PE Ratio0

Dividend0

Process Industries

Chemicals: Specialty

24.5K

Natural Biocon (India) Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

Market Cap
10.31
Net Profit
0.04
P/B
1.20
Sector P/E
73.42
P/E
742
EV/EBITDA
0
Debt/Equity (Industry)
0.65
Interest Cover (Industry)
4.79
ROCE (Industry)
18.39
RONW (Industry)
17.80
ROE
0.18
ROCE
0.27
Debt/Equity
0.01
EPS (TTM)
0
Dividend Yield
0
Book Value
12.40
Interest Cover
0

Analysis

all

Pros

Natural Biocon (India) is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Natural Biocon (India) has been profitable on average in the past, therefore cash runway is not a concern.
Natural Biocon (India) has been profitable on average in the past, therefore cash runway is not a concern.
Debt is covered by short term assets, assets are 1.6x debt.
Natural Biocon (India)'s cash and other short term assets cover its long term commitments.

Cons

Unable to evaluate Natural Biocon (India)'s dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
Unable to evaluate Natural Biocon (India)'s dividend against the top 25% market benchmark as the company has not reported any payouts.
Operating cash flow is negative therefore debt is not well covered.
High level of physical assets or inventory.
The average tenure for the Natural Biocon (India) board of directors is less than 3 years, this suggests a new board.

Financials

No Result Found

Ratios

No Result Found

Shareholders	DEC 2025	SEPT 2025	JUN 2025	MAR 2025	DEC 2024
Promoters	9.36	9.36	9.36	9.36	9.36
FII	0	0	0	0	0
DII	0	0	0	0	0
Public	90.64	90.64	90.64	90.64	90.64
Government	0	0	0	0	0

Technical Analysis

RSI

MACD

50 DMA

200 DMA

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	-	-	-	-	-	-	-
Fibonacci	-	-	-	-	-	-	-
Camarilla	-	-	-	-	-	-	-

Pivots Level: Classic

Pivot Point

LTP: -

Moving Average

SMAEMA

Period

Value

10-EMA
-
20-EMA
-
30-EMA
-
50-EMA
-
100-EMA
-
200-EMA
-

Announcement Date	Purpose	Action
13 Feb 2026	board-meetings	Quarterly Results
15 Sept 2025	agm
04 Nov 2024	egm
16 Sept 2024	agm
02 May 2024	egm
26 Aug 2023	agm
12 Sept 2022	agm
01 Sept 2021	agm

Peer Comparison

No Result Found

Natural Biocon (India) Ltd

Aditya Birla Lifestyle Brands Ltd

Brainbees Solutions Ltd

Trent Ltd

Vishal Mega Mart Ltd

Avenue Supermarts Ltd

Natural Biocon (India) Ltd About

Natural Biocon (India) operates in business of trading of agricultural produce.

Industry

Trading

Founded

1992

Headquarters

CEO

Arunkumar D Prajapati

Employees

Contact

Website

http://www.naturalbiocon.com

info@naturalbiocon.com; naturalbioconindia@gmail.c

Phone

265-433286

Location

E/49, Sardar Estate, Ajwa Road, Vadodara, Gujarat, 390019

Year	History
1992	Natural Biocon (India) Ltd. was incorporated in the state of Gujarat.

Client Name	Order Side	QTY	Avg Price	Date
CHOKSHI DIMPLE	Buy	435462	4.49	23 Jan 2026
VIJAYKUMAR JAYANTILAL THAKKAR	Sell	368000	4.5	23 Jan 2026
CHOKSHI DIMPLE	Buy	267108	4.75	17 Nov 2025
MAQBOOL BASHA SYED	Sell	135144	4.61	17 Nov 2025
BANU SHAKEELA	Sell	352359	4.63	17 Nov 2025
ANAND SINGH THAKUR	Sell	164000	5.14	14 Nov 2025
ARUNKUMAR DASHRATHBHAI PRAJAPATI HUF	Buy	786787	5.54	13 Nov 2025
CHOKSHI DIMPLE	Sell	613190	5.55	13 Nov 2025
ARUNKUMAR	Sell	284132	6	11 Nov 2025
PRAVEEN PAHUJA	Sell	299447	5.98	20 Oct 2025

Natural Biocon (India) Ltd News

Natural Biocon Q3FY26 Results Show Revenue Decline

Natural Biocon (India) Limited reported zero revenue for Q3FY26 ended December 31, 2025, compared to ₹127.73 lakhs in Q3FY25, resulting in a net loss of ₹4.27 lakhs.

13 Feb 2026

co actions results

Natural Biocon Reports Mixed Q2 Results with Zero Revenue and Rs 4.37 Lakh Loss

Natural Biocon (India) Limited reported zero net sales for Q2 ended September 30, 2025, resulting in a loss of Rs 4.37 lakhs, compared to Rs 20.24 lakhs profit in the same quarter last year. The company's half-year results showed profit of Rs 9.49 lakhs with revenue of Rs 166.57 lakhs, significantly lower than Rs 29.99 lakhs profit and Rs 572.34 lakhs revenue in the previous year's corresponding period.

01 Dec 2025

earnings

Natural Biocon Reports Mixed Financial Performance in Second Quarter Results

Natural Biocon (India) Limited's Board approved unaudited financial results for the second quarter and half year ended September 30, 2025, showing a net loss after tax of Rs. 4.37 lakhs for the quarter compared to a profit of Rs. 20.24 lakhs in the previous quarter. The company's total income from operations decreased to Rs. 166.87 lakhs for the half year compared to Rs. 572.58 lakhs in the previous year, while maintaining an equity share capital of Rs. 2578.28 lakhs.

19 Nov 2025

earnings

Natural Biocon India Reports 42% Jump in Net Profit for Q1 FY2026

Natural Biocon (India) Limited reported a net profit of Rs 13.86 lakhs for the quarter ended June 30, 2025, compared to Rs 9.75 lakhs in the same period last year. Revenue from operations increased to Rs 166.57 lakhs from Rs 98.65 lakhs year-on-year. The company's total expenses rose to Rs 152.71 lakhs from Rs 88.90 lakhs in the corresponding quarter. Basic and diluted earnings per share stood at Rs 0.05. The Board of Directors approved these unaudited financial results during their meeting held on August 13, 2025. The company operates in a single business segment and is listed on BSE and Calcutta Stock Exchange.

13 Aug 2025

earnings

Biocon Receives Approval for Liraglutide Drug in India

Biocon has received approval for the generic version of Victoza, a drug containing Liraglutide, in India. This medication is used for the treatment of Type 2 diabetes.

02 Jun 2025

default

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800